-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
September 20th is the 34th "National Love Tooth Day", this year's activity theme is "Oral Health and Whole Body Health", and the sub-theme is "Teeth Care and Healthy Teenagers Strong and Healthy Chinese National Prosperity", aiming to implement the guidelines and policies of the "Healthy China Action (2019-2030)" and "Healthy Oral Action Plan (2019-2025)", improve the public's oral health literacy, and create a social atmosphere
conducive to oral health.
conducive to oral health.
In daily life, we often encounter sore toothache, in fact, most of this is caused
by gingivitis and periodontitis, caries (tooth decay) or broken teeth leading to pulp (tooth nerve) infection.
Therefore, dental treatment drugs are mainly divided into anti-inflammatory drugs and analgesic drugs, common anti-inflammatory drugs are antibiotics, including broad-spectrum antibiotics, anaerobic antibiotics, etc.
, while analgesic drugs are usually not much different from the analgesic drugs of other departments, such as non-steroidal anti-inflammatory drugs and antipyretic analgesics
.
by gingivitis and periodontitis, caries (tooth decay) or broken teeth leading to pulp (tooth nerve) infection.
Therefore, dental treatment drugs are mainly divided into anti-inflammatory drugs and analgesic drugs, common anti-inflammatory drugs are antibiotics, including broad-spectrum antibiotics, anaerobic antibiotics, etc.
, while analgesic drugs are usually not much different from the analgesic drugs of other departments, such as non-steroidal anti-inflammatory drugs and antipyretic analgesics
.
Dentistry belongs to the Department of Stomatology, in the PDB database, dental drugs do not have a separate treatment sub-category, so this paper analyzes
the sales amount and changes of dental drugs, mainly and several key drugs used in dentistry in sample hospitals, average unit price, etc.
the sales amount and changes of dental drugs, mainly and several key drugs used in dentistry in sample hospitals, average unit price, etc.
Oral sales increased by nearly 30% last year
PDB data shows that in 2021, the sales of stomatology drugs in the sample hospitals will be 0.
46 billion yuan, and the amount of drugs purchased in public hospitals nationwide will be about 164 million yuan
.
Sales of sample hospitals in 2021 were the highest in nearly five years, an increase of 28.
2% compared to 2020, and a year-on-year increase of 12.
2%
in the first quarter of 2022.
From the perspective of average unit price, the overall trend
is rising year by year.
46 billion yuan, and the amount of drugs purchased in public hospitals nationwide will be about 164 million yuan
.
Sales of sample hospitals in 2021 were the highest in nearly five years, an increase of 28.
2% compared to 2020, and a year-on-year increase of 12.
2%
in the first quarter of 2022.
From the perspective of average unit price, the overall trend
is rising year by year.
From the perspective of drugs, in the oral medicine, excluding oral ulcers and stomatitis drugs, the sales amount of dental drugs in the sample hospital in 2021 is 0.
34 billion yuan, accounting for about 73.
9% of the oral drugs, with a total of 12 drugs (14 dosage forms).
The top three are povidone iodine gargle, cepyridinium chloride lozenges and cepyridinium chloride gargles, with a total sales of more than 26 million yuan in the sample hospitals, accounting for 74.
7% of dental drug sales and 80.
1%
of sales volume.
The highest unit price is 96.
77 yuan of povidone iodine gargle, and the lowest unit price is 0.
12 yuan
of furfuryl sterol tablets.
34 billion yuan, accounting for about 73.
9% of the oral drugs, with a total of 12 drugs (14 dosage forms).
The top three are povidone iodine gargle, cepyridinium chloride lozenges and cepyridinium chloride gargles, with a total sales of more than 26 million yuan in the sample hospitals, accounting for 74.
7% of dental drug sales and 80.
1%
of sales volume.
The highest unit price is 96.
77 yuan of povidone iodine gargle, and the lowest unit price is 0.
12 yuan
of furfuryl sterol tablets.
It can be seen that the products with the word "tooth" in the trade name, such as compound fenbufen + metronidazole capsules (periodontal kang), furfuryl sterol tablets (periodontal anam), camphor hydrate chloral tincture (toothache water, Xinlong toothache), artificial bovine yellow metronidazole capsules (toothache, toothache) and so on are not large
in the sample hospital.
in the sample hospital.
There is a clear gap between the rise and fall of the combined use of therapeutic drugs
In addition to the above-mentioned dental treatment drug dosage forms classified in stomatological drugs, there are also some drugs that are mainly used in dental treatment, such as metronidazole, ornidazole, tinidazole and so on
of anaerobic antibiotics.
of anaerobic antibiotics.
It can be seen from the sales data of PDB sample hospitals that metronidazole and tinidazole have shown a gradual growth trend in the past three years, and the sales in the sample hospitals in 2021 are 0.
38 billion yuan and 0.
08 billion yuan, respectively, while ornidazole is currently maintained at about
220 million yuan after a sharp decline in 2020.
From the average unit price, metronidazole is the lowest price among the three and sales are declining year by year, and ornidazole is the highest price but sales are also declining
year by year.
38 billion yuan and 0.
08 billion yuan, respectively, while ornidazole is currently maintained at about
220 million yuan after a sharp decline in 2020.
From the average unit price, metronidazole is the lowest price among the three and sales are declining year by year, and ornidazole is the highest price but sales are also declining
year by year.
In addition, some NSAIDs and antipyretic analgesics (PDB database TCM prescription analysis system RAS shows about 10% to 12%) for dental analgesia
.
.
In 2021, the sales of nonsteroidal anti-inflammatory drugs sample hospitals were 1.
837 billion yuan (the amount of drugs purchased in public hospitals nationwide was about 5.
309 billion yuan), and the sales of antipyretic analgesics samples in hospitals were 322 million yuan, and the sales of nonsteroidal anti-inflammatory drugs and antipyretic analgesics in the sample hospitals in the past three years showed a downward trend, but the overall sales volume was rising, and the average price was also declining year by year, which showed that some products played a role
in promoting the increase in volume and price after entering the national collection.
837 billion yuan (the amount of drugs purchased in public hospitals nationwide was about 5.
309 billion yuan), and the sales of antipyretic analgesics samples in hospitals were 322 million yuan, and the sales of nonsteroidal anti-inflammatory drugs and antipyretic analgesics in the sample hospitals in the past three years showed a downward trend, but the overall sales volume was rising, and the average price was also declining year by year, which showed that some products played a role
in promoting the increase in volume and price after entering the national collection.
September 20th is the 34th "National Love Tooth Day", this year's activity theme is "Oral Health and Whole Body Health", and the sub-theme is "Teeth Care and Healthy Teenagers Strong and Healthy Chinese National Prosperity", aiming to implement the guidelines and policies of the "Healthy China Action (2019-2030)" and "Healthy Oral Action Plan (2019-2025)", improve the public's oral health literacy, and create a social atmosphere
conducive to oral health.
conducive to oral health.
In daily life, we often encounter sore toothache, in fact, most of this is caused
by gingivitis and periodontitis, caries (tooth decay) or broken teeth leading to pulp (tooth nerve) infection.
Therefore, dental treatment drugs are mainly divided into anti-inflammatory drugs and analgesic drugs, common anti-inflammatory drugs are antibiotics, including broad-spectrum antibiotics, anaerobic antibiotics, etc.
, while analgesic drugs are usually not much different from the analgesic drugs of other departments, such as non-steroidal anti-inflammatory drugs and antipyretic analgesics
.
by gingivitis and periodontitis, caries (tooth decay) or broken teeth leading to pulp (tooth nerve) infection.
Therefore, dental treatment drugs are mainly divided into anti-inflammatory drugs and analgesic drugs, common anti-inflammatory drugs are antibiotics, including broad-spectrum antibiotics, anaerobic antibiotics, etc.
, while analgesic drugs are usually not much different from the analgesic drugs of other departments, such as non-steroidal anti-inflammatory drugs and antipyretic analgesics
.
Dentistry belongs to the Department of Stomatology, in the PDB database, dental drugs do not have a separate treatment sub-category, so this paper analyzes
the sales amount and changes of dental drugs, mainly and several key drugs used in dentistry in sample hospitals, average unit price, etc.
the sales amount and changes of dental drugs, mainly and several key drugs used in dentistry in sample hospitals, average unit price, etc.
Oral sales increased by nearly <>% last year
Oral sales increased by nearly 30% last year PDB data shows that in 2021, the sales of stomatology drugs in the sample hospitals will be 0.
46 billion yuan, and the amount of drugs purchased in public hospitals nationwide will be about 164 million yuan
.
Sales of sample hospitals in 2021 were the highest in nearly five years, an increase of 28.
2% compared to 2020, and a year-on-year increase of 12.
2%
in the first quarter of 2022.
From the perspective of average unit price, the overall trend
is rising year by year.
46 billion yuan, and the amount of drugs purchased in public hospitals nationwide will be about 164 million yuan
.
Sales of sample hospitals in 2021 were the highest in nearly five years, an increase of 28.
2% compared to 2020, and a year-on-year increase of 12.
2%
in the first quarter of 2022.
From the perspective of average unit price, the overall trend
is rising year by year.
From the perspective of drugs, in the oral medicine, excluding oral ulcers and stomatitis drugs, the sales amount of dental drugs in the sample hospital in 2021 is 0.
34 billion yuan, accounting for about 73.
9% of the oral drugs, with a total of 12 drugs (14 dosage forms).
The top three are povidone iodine gargle, cepyridinium chloride lozenges and cepyridinium chloride gargles, with a total sales of more than 26 million yuan in the sample hospitals, accounting for 74.
7% of dental drug sales and 80.
1%
of sales volume.
The highest unit price is 96.
77 yuan of povidone iodine gargle, and the lowest unit price is 0.
12 yuan
of furfuryl sterol tablets.
Pharmaceuticals and Medicines Hospital Hospital34 billion yuan, accounting for about 73.
9% of the oral drugs, with a total of 12 drugs (14 dosage forms).
The top three are povidone iodine gargle, cepyridinium chloride lozenges and cepyridinium chloride gargles, with a total sales of more than 26 million yuan in the sample hospitals, accounting for 74.
7% of dental drug sales and 80.
1%
of sales volume.
The highest unit price is 96.
77 yuan of povidone iodine gargle, and the lowest unit price is 0.
12 yuan
of furfuryl sterol tablets.
It can be seen that the products with the word "tooth" in the trade name, such as compound fenbufen + metronidazole capsules (periodontal kang), furfuryl sterol tablets (periodontal anam), camphor hydrate chloral tincture (toothache water, Xinlong toothache), artificial bovine yellow metronidazole capsules (toothache, toothache) and so on are not large
in the sample hospital.
in the sample hospital.
There is a clear gap between the rise and fall of the combined use of therapeutic drugs
There is a clear gap between the rise and fall of the combined use of therapeutic drugs In addition to the above-mentioned dental treatment drug dosage forms classified in stomatological drugs, there are also some drugs that are mainly used in dental treatment, such as metronidazole, ornidazole, tinidazole and so on
of anaerobic antibiotics.
of anaerobic antibiotics.
It can be seen from the sales data of PDB sample hospitals that metronidazole and tinidazole have shown a gradual growth trend in the past three years, and the sales in the sample hospitals in 2021 are 0.
38 billion yuan and 0.
08 billion yuan, respectively, while ornidazole is currently maintained at about
220 million yuan after a sharp decline in 2020.
From the average unit price, metronidazole is the lowest price among the three and sales are declining year by year, and ornidazole is the highest price but sales are also declining
year by year.
38 billion yuan and 0.
08 billion yuan, respectively, while ornidazole is currently maintained at about
220 million yuan after a sharp decline in 2020.
From the average unit price, metronidazole is the lowest price among the three and sales are declining year by year, and ornidazole is the highest price but sales are also declining
year by year.
In addition, some NSAIDs and antipyretic analgesics (PDB database TCM prescription analysis system RAS shows about 10% to 12%) for dental analgesia
.
TCM.
In 2021, the sales of nonsteroidal anti-inflammatory drugs sample hospitals were 1.
837 billion yuan (the amount of drugs purchased in public hospitals nationwide was about 5.
309 billion yuan), and the sales of antipyretic analgesics samples in hospitals were 322 million yuan, and the sales of nonsteroidal anti-inflammatory drugs and antipyretic analgesics in the sample hospitals in the past three years showed a downward trend, but the overall sales volume was rising, and the average price was also declining year by year, which showed that some products played a role
in promoting the increase in volume and price after entering the national collection.
837 billion yuan (the amount of drugs purchased in public hospitals nationwide was about 5.
309 billion yuan), and the sales of antipyretic analgesics samples in hospitals were 322 million yuan, and the sales of nonsteroidal anti-inflammatory drugs and antipyretic analgesics in the sample hospitals in the past three years showed a downward trend, but the overall sales volume was rising, and the average price was also declining year by year, which showed that some products played a role
in promoting the increase in volume and price after entering the national collection.
